BIOMAT Database Logo BIOMAT Database Logo

Does fluconazole prevent cryptococcal meningitis in human immunodeficiency virus-infected patients? 1992

C Pradier, and E Bernard, and C Lubick, and M Toussaint-Gari, and Y Pinier, and J Durant, and V Mondain, and Y Le Fichoux, and P Dellamonica

UI MeSH Term Description Entries
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D015725 Fluconazole Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS. Apo-Fluconazole,Béagyne,Diflucan,Fluc Hexal,FlucoLich,Flucobeta,Fluconazol AL,Fluconazol AbZ,Fluconazol Stada,Fluconazol von ct,Fluconazol-Isis,Fluconazol-ratiopharm,Flunazul,Fungata,Lavisa,Loitin,Neofomiral,Oxifungol,Solacap,Triflucan,UK-49858,Zonal,Apo Fluconazole,Fluconazol Isis,Fluconazol ratiopharm,UK 49858,UK49858
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D016919 Meningitis, Cryptococcal Meningeal inflammation produced by CRYPTOCOCCUS NEOFORMANS, an encapsulated yeast that tends to infect individuals with ACQUIRED IMMUNODEFICIENCY SYNDROME and other immunocompromised states. The organism enters the body through the respiratory tract, but symptomatic infections are usually limited to the lungs and nervous system. The organism may also produce parenchymal brain lesions (torulomas). Clinically, the course is subacute and may feature HEADACHE; NAUSEA; PHOTOPHOBIA; focal neurologic deficits; SEIZURES; cranial neuropathies; and HYDROCEPHALUS. (From Adams et al., Principles of Neurology, 6th ed, pp721-2) Cryptococcal Meningitis,Granulomous Cerebral Cryptococcosis,Toruloma,Cerebral Cryptococcosis,Cerebral Cryptococcoses,Cerebral Cryptococcoses, Granulomous,Cerebral Cryptococcosis, Granulomous,Cryptococcal Meningitides,Cryptococcoses, Cerebral,Cryptococcoses, Granulomous Cerebral,Cryptococcosis, Cerebral,Cryptococcosis, Granulomous Cerebral,Granulomous Cerebral Cryptococcoses,Meningitides, Cryptococcal,Torulomas

Related Publications

C Pradier, and E Bernard, and C Lubick, and M Toussaint-Gari, and Y Pinier, and J Durant, and V Mondain, and Y Le Fichoux, and P Dellamonica
Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe.
February 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
C Pradier, and E Bernard, and C Lubick, and M Toussaint-Gari, and Y Pinier, and J Durant, and V Mondain, and Y Le Fichoux, and P Dellamonica
High Cryptococcal Antigen Titers in Blood Are Predictive of Subclinical Cryptococcal Meningitis Among Human Immunodeficiency Virus-Infected Patients.
February 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
C Pradier, and E Bernard, and C Lubick, and M Toussaint-Gari, and Y Pinier, and J Durant, and V Mondain, and Y Le Fichoux, and P Dellamonica
Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis.
November 2009, International journal of antimicrobial agents,
C Pradier, and E Bernard, and C Lubick, and M Toussaint-Gari, and Y Pinier, and J Durant, and V Mondain, and Y Le Fichoux, and P Dellamonica
Primary prevention of cryptococcal meningitis by fluconazole in HIV-infected patients.
March 1995, Lancet (London, England),
C Pradier, and E Bernard, and C Lubick, and M Toussaint-Gari, and Y Pinier, and J Durant, and V Mondain, and Y Le Fichoux, and P Dellamonica
Induction therapy with high-dose fluconazole plus flucytosine for human immunodeficiency virus-uninfected cryptococcal meningitis patients: Feasible or not?
January 2023, Mycoses,
C Pradier, and E Bernard, and C Lubick, and M Toussaint-Gari, and Y Pinier, and J Durant, and V Mondain, and Y Le Fichoux, and P Dellamonica
Cryptococcal meningitis in human immunodeficiency virus (HIV)-positive and HIV-negative patients.
January 2004, The Southeast Asian journal of tropical medicine and public health,
C Pradier, and E Bernard, and C Lubick, and M Toussaint-Gari, and Y Pinier, and J Durant, and V Mondain, and Y Le Fichoux, and P Dellamonica
Tuberculous meningitis in patients infected with human immunodeficiency virus.
January 2011, Journal of neurology,
C Pradier, and E Bernard, and C Lubick, and M Toussaint-Gari, and Y Pinier, and J Durant, and V Mondain, and Y Le Fichoux, and P Dellamonica
Cryptococcal meningitis and fluconazole.
May 1987, Annals of internal medicine,
C Pradier, and E Bernard, and C Lubick, and M Toussaint-Gari, and Y Pinier, and J Durant, and V Mondain, and Y Le Fichoux, and P Dellamonica
Fluconazole-resistant cryptococcal meningitis.
June 2003, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
C Pradier, and E Bernard, and C Lubick, and M Toussaint-Gari, and Y Pinier, and J Durant, and V Mondain, and Y Le Fichoux, and P Dellamonica
Fluconazole for cryptococcal meningitis.
January 1989, Annals of internal medicine,
Copied contents to your clipboard!